Clinical Takeaway Trauma-focused treatments for PTSD remain effective even among patients who use cannabis, including those with co-occurring substance use disorders. Cannabis use does not appear to undermine the benefits of evidence-based...
`Endocannabinoid System Research: Cannabis for PTSD & SUD`
Clinical Takeaway Trauma-focused treatments remain effective for PTSD even in patients who use cannabis, including those with co-occurring substance use disorders. Cannabis use at baseline does not appear to undermine the benefit...
`Cannabinoid Clinical Trials: PTSD and Substance Use Disorders`
Clinical Takeaway Trauma-focused therapy remains effective for PTSD even in patients who are actively using cannabis, including those with co-occurring substance use disorders. Patients should not be required to stop cannabis use...
`Endocannabinoid System Research: Cannabis for PTSD & SUD`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...
`Cannabinoid Clinical Trials: PTSD and Substance Use Meta-Analysis`
Clinical Takeaway People with PTSD who use cannabis respond just as well to trauma-focused therapies as those who do not use cannabis, even when a co-occurring substance use disorder is present. Trauma-focused...
`Endocannabinoid System Research: Cannabis for PTSD + SUD`
Clinical Takeaway Trauma-focused therapies remain effective for PTSD even when patients are actively using cannabis, including those with co-occurring substance use disorders. Clinicians should not withhold or delay evidence-based PTSD treatment due...
`Endocannabinoid System Research: Cannabis for PTSD and SUD`
Clinical Takeaway Trauma-focused therapy remains effective for PTSD even in patients who use cannabis, including those with co-occurring substance use disorders. Patients should not be excluded from or delayed in receiving evidence-based...